Cite
MLA Citation
Solmaz Sahebjam et al.. “287 Safety and antitumor activity of indoleamine 2, 3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A175–A176. http://access.bl.uk/ark:/81055/vdc_100144727911.0x000004